What is stem cell therapy? The vocabulary, decoded

"Stem cell therapy" is a storefront phrase covering more than one procedure. Behind the Portland version NW Regen describes sits one sequence: fat tissue taken from the patient, worked into a graft, put back under live ultrasound into the structure that hurts.

Three words that carry the weight

NW Regen's service page does at least define its terms.

Autologous
From the patient's own fatty tissue. The only consequence the service page draws from it: the body won't reject it.
Adipose
Fat tissue, described as holding several kinds of healthy cells and chosen because it is simple to collect and supplies cellular, biological and structural support, scaffolding included.
Biocellular
A modifier rather than a category above the rest: NW Regen sets its biocellular injection therapies and its stem cell IV therapies side by side, both aimed at ligaments, tendons, muscles, skin, and regrowing hair.

MFAT, MSC, ECM

Three acronyms do the explaining. MFAT, micro-fragmented adipose tissue, is the graft itself. MSCs, glossed as medicinal signaling cells and also as mesenchymal stem cells, are the pluripotent, regenerative cells said to be concentrated in it. ECM, the extracellular matrix, is connective-tissue scaffolding — mortar between bricks, in the page's own analogy.

ECM is the pivot of the argument for fat over marrow, which brings none of it. The second argument is raw cell count, where the figures published differ: one passage puts MFAT concentrations at roughly 500 to 2,000 times those of marrow, the FAQ below it at about a thousand. Worth asking which figure a provider stands behind.

One label, three procedures

The distinction marketing collapses is set out plainly on the Portland stem cell therapy service page NW Regen publishes, separating three adipose-derived therapies.

What a treatment day involves

The harvest is described as minimally invasive: a closed, low-force liposuction under real-time imaging, processed in the lab on site. NW Regen puts a culture-expansion visit at roughly two hours, opening with a local anesthetic for comfort; the sample ships overnight to a partnered cell bank, where expansion runs about six weeks before the cells return for that patient alone. A same-day procedure is given as about four hours, the difference being that platelet-rich plasma is prepared first and injected alongside the graft, and some patients take both routes. Dr. Ryan Wood is named as the physician injecting, always under live ultrasound.

What the clinic says it is for

Two pages carry indications, and they are not interchangeable. Only the service page is about adipose-derived biocellular therapy itself, and this is its list.

The second page, orthopedic injuries and trauma, is wider than this subject: it gathers four injection therapies under one heading — prolotherapy, PRP, the biocellular grafts and perineural injection — without saying which treats what. So the conditions below are ones NW Regen treats with regenerative injection therapy generally. Read them as that, not as a stem cell indication list.

How the claim is actually worded

The stated aim is to help reverse degenerative processes and prevent further ones, restore or repair aging and damaged tissue, and reduce the need for surgery. Most patients, the page says, experience reduced pain and inflammation and can return to more normal life activities — a statement about most patients, not one joint. Dr. Wood's account of the mechanism is that these cells put out bioactive signaling molecules with immunomodulatory, antimicrobial, angiogenic and regenerative effects, producing change local and specific to the tissue. Afterwards, the page offers one line: most people typically have post-treatment discomfort that resolves after several days. That is not a risk discussion, and the page sends prospective patients to Dr. Wood to settle which path suits them. More of the clinic's own writing is excerpted in the stem cell article library.

The service page is not where the clinic's risk wording lives, though. Its articles go further, and that part belongs here too: stem cell injections carry risks like any medical procedure, among them infection, bleeding and allergic reactions, and in rare cases complications from the anesthetic. The clinic's own instruction is to work through those with a healthcare provider before agreeing to treatment. On MFAT it adds pain or swelling at the injection site and, because a liposuction step is involved, a slightly raised chance of infection or bruising, which it says proper aftercare reduces substantially.

Sources

Everything on this page is drawn from pages published by NW Regen: